Abeona Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4,909.1% | +49.7% | -10.2% | +218.5% | +267.7% | -35.5% | -20.3% | +2.5% | -30.1% | -9.1% | +22.6% | |
| – | +234.7% | +10.6% | +22.5% | +49.9% | -7.1% | -0.6% | +8.9% | -65.8% | +56.3% | +39.0% | +62.6% | |
| – | -80.7% | +1.3% | -6.5% | +67.2% | -2.8% | +472.1% | -21.2% | – | – | – | – | |
| – | -1,648.2% | – | – | – | -151.0% | – | -1,217.7% | – | – | – | – | |
| – | +0.0% | +68.5% | +65.7% | +2,166.7% | -66.6% | -79.5% | +210.7% | -96.9% | +154.6% | +639.0% | +226.0% | |
| – | +0.0% | -115.3% | +65.7% | +9,793.7% | – | -239.6% | – | -136.3% | – | -18,965.4% | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -5.5% | +265.6% | +117.2% | -94.1% | +227.4% | -99.0% | -100.0% | – | -99.3% | – | – | |
| – | -200.0% | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | -100.0% | |
| – | +180.6% | +19.3% | +117.2% | -94.1% | +1,979.6% | -98.3% | +1,184.1% | +73.7% | -14.2% | +181.0% | -75.0% | |
| – | +157.9% | +1.3% | +136.5% | -273.0% | – | -205.2% | – | -196.1% | – | +3,370.3% | +516.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.